Healthcare Triangle, Inc.
General ticker "HCTI" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $55.9K (TTM average)
Healthcare Triangle, Inc. does not follow the US Stock Market performance with the rate: -21.9%.
Estimated limits based on current volatility of 3.2%: low 0.80$, high 0.85$
Factors to consider:
- Total employees count: 33 as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Market competition, Cybersecurity threats, Strategic risks and growth management, Regulatory and compliance, Customer concentration
- Current price 97.4% below estimated low
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [31.76$, 144.97$]
- 2026-12-31 to 2027-12-31 estimated range: [21.57$, 93.72$]
Financial Metrics affecting the HCTI estimates:
- Negative: with PPE of -0.7 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -425.14 <= 0.28
- Negative: negative Net income
- Negative: Investing cash flow per share per price, % of -45.05 <= -14.39
- Negative: negative Industry operating cash flow (median)
- Negative: Industry earnings per price (median), % of 0 <= 0
- Negative: Interest expense per share per price, % of 14.59 > 3.34
- Negative: -0.14 < Industry inventory ratio change (median), % of -0.11
- Negative: negative Industry operating income (median)
- Negative: 42.26 < Shareholder equity ratio, % of 43.90 <= 63.63
Short-term HCTI quotes
Long-term HCTI plot with estimates
Financial data
| YTD | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Operating Revenue | $11.70MM | $13.89MM |
| Operating Expenses | $16.45MM | $23.68MM |
| Operating Income | $-4.75MM | $-9.79MM |
| Non-Operating Income | $-1.21MM | $0.31MM |
| Interest Expense | $1.21MM | $0.57MM |
| R&D Expense | $0.43MM | $0.54MM |
| Income(Loss) | $-5.96MM | $-9.48MM |
| Taxes | $0.01MM | $0.00MM |
| Net Income(Loss)* | $-5.97MM | $-9.48MM |
| Stockholders Equity | $-5.11MM | $9.98MM |
| Assets | $1.96MM | $22.74MM |
| Operating Cash Flow | $-1.08MM | $-16.52MM |
| Capital expenditure | $0.00MM | $0.01MM |
| Investing Cash Flow | $0.00MM | $-1.75MM |
| Financing Cash Flow | $-0.13MM | $25.88MM |
| Earnings Per Share** | $-16,895.02 | $-153.16 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.